+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Europe Mobile Cardiac Telemetry Systems Market to 2027 - Regional Analysis and Forecasts by Technology; End User, and Country

  • PDF Icon

    Report

  • 109 Pages
  • September 2019
  • Region: Europe
  • The Insight Partners
  • ID: 4847167
UP TO OFF until Jun 30th 2024
The Europe mobile cardiac telemetry systems market is expected to reach US$ 477,845.5 Mn in 2027 from US$ 167,462.4 Mn in 2018. The market is estimated to grow with a CAGR of 13.0% from 2019-2027.

The growth of the mobile cardiac telemetry systems market is primarily attributed to the rising prevalence of cardiovascular diseases and increasing elderly population. However, high cost of products and procedures is likely to pose a negative impact on the market growth. On the other hand, offering high quality services for cardiovascular diseases is likely to have a positive impact on the growth of the Europe mobile cardiac telemetry systems market in the coming years.

Cardiovascular diseases (CVDs) are the heart and blood vessels related disorders that include cerebrovascular disease, coronary heart disease, rheumatic heart disease and other conditions. Some of the major factors which leads to the death and difficulties are use of tobacco, unhealthy diet, and physical inactivity which increases the risk of heart attacks and strokes. CVDs are the leading cause of death across the globe, it affects more people as compared to any other disease. According to the World Health Organization’s Fact sheet on cardiovascular diseases, in 2016, approximately 17.9 million people died from CVDs, which was 31.0% of all the global deaths. Among these approximately 85% were due to heart attack and stroke. Heart attacks and strokes are mainly caused due to fatty deposits that block the blood vessels that prevents blood from flowing to the heart or brain. Strokes are also caused due to bleeding from a blood vessel in the brain or from blood clots. Heart attacks and strokes are caused due to increased consumption of tobacco use, unhealthy diet and obesity, physical inactivity and rising alcohol consumption, hypertension, and diabetes. According to the European Cardiovascular Disease Statistics 2017, in Europe, every year cardiovascular disease (CVD) causes 3.9 million deaths and more than 1.8 million deaths in the European Union (EU). Off all the deaths occurring in Europe, 45% is accounted by CVD alone. CVD is the major reason of the death in men and women in all countries. Owing to the rising cases of cardiovascular diseases across various countries, the need and demand for the mobile cardiac telemetry systems for the treatment of the CVD is expected to increase in the coming years.

In 2018, the lead based segment held a largest market share of the mobile cardiac telemetry systems market, by technology. The lead based segment is expected to dominate its market share in 2027 owing to the advantages offered by the lead based systems for monitoring the heart conditions. The patch based segment is anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027 owing to the technological advancements in the medical devices that allows the clinicians to perform the patient diagnostic process without delay and it also minimizes the handling risks.

In 2018, the hospitals held a largest market share of the mobile cardiac telemetry systems market, by end user. This segment is also expected to dominate the market in 2027 owing to the need for the cardiovascular surgery treatments that has become the major factor for the growth of the mobile cardiac telemetry systems market. Also the hospitals segment is expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.

Some of the major primary and secondary sources for mobile cardiac telemetry systems included in the report are, Body Sensor Networks (BSN), Centers for Disease Control and Prevention (CDC), Cardiovascular Disease Prevention And Rehabilitation (CVDPR), National Diagnosis-Related Group (DRG), World Health Organization (WHO) and others.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the mobile cardiac telemetry systems market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the mobile cardiac telemetry systems market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
2. Europe Mobile Cardiac Telemetry Systems Market - Key Takeaways
3. Europe Mobile Cardiac Telemetry Systems Market - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Mobile Cardiac Telemetry Systems Market - By Technology
3.2.2 Europe Mobile Cardiac Telemetry Systems Market - By End User
3.2.3 Europe Mobile Cardiac Telemetry Systems Market - By Country
3.3 PEST Analysis
4. Europe Mobile Cardiac Telemetry Systems Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Prevalence of Cardiovascular Diseases
4.1.2 Increasing Elderly Population
4.2 Key Market Restraints
4.2.1 High Cost of Products and Procedures
4.3 Key Market Opportunities
4.3.1 Offering High Quality Services For Cardiovascular Diseases
4.4 Future Trends
4.4.1 Increasing Prevalence of Cardiovascular Diseases in Germany
4.5 Impact Analysis
5. Mobile Cardiac Telemetry Systems Market - Europe Analysis
5.1 Europe Mobile Cardiac Telemetry Systems Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.2.1 Welch Allyn
5.2.2 BioTelemetry, Inc.
6. Europe Mobile Cardiac Telemetry Systems Market Analysis - By Technology
6.1 Overview
6.2 Europe Mobile Cardiac Telemetry Systems Market By Technology, 2018 & 2027 (%)
6.3 Europe Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
6.4 Lead Based Market
6.4.1 Overview
6.4.2 Europe Lead Based Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Patch Based Market
6.5.1 Overview
6.5.2 Europe Patch Based Market Revenue and Forecast to 2027 (US$ Mn)
7. Europe Mobile Cardiac Telemetry Systems Market Analysis - By End User
7.1 Overview
7.2 Europe Mobile Cardiac Telemetry Systems Market, By End User, 2018 & 2027 (%)
7.3 Europe Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By End User (US$ Mn)
7.4 Hospitals
7.4.1 Overview
7.4.2 Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Cardiac Centres
7.5.1 Overview
7.5.2 Europe Cardiac Centres Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Ambulatory surgical Centres
7.6.1 Overview
7.6.2 Europe Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)
8. Europe Mobile Cardiac Telemetry Systems Market Revenue and Forecasts To 2027
8.1 Overview
8.2 Europe Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027 (US$ Mn)
8.3 Europe Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
8.4 Europe Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.5 Europe Mobile Cardiac Telemetry Systems Market Revenue and Forecasts to 2027, By Country (%)
8.6 Germany Mobile Cardiac Telemetry Systems Market Revenue and Forecasts To 2027 (US$ Mn)
8.6.1 Germany Mobile Cardiac Telemetry Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Germany Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
8.8 Germany Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.9 UK Mobile Cardiac Telemetry Systems Market Revenue and Forecasts To 2027 (US$ Mn)
8.9.1 UK Mobile Cardiac Telemetry Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.10 UK Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
8.11 UK Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.12 France Mobile Cardiac Telemetry Systems Market Revenue and Forecasts To 2027 (US$ Mn)
8.12.1 France Mobile Cardiac Telemetry Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.13 France Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
8.14 France Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.15 Spain Mobile Cardiac Telemetry Systems Market Revenue and Forecasts To 2027 (US$ Mn)
8.15.1 Spain Mobile Cardiac Telemetry Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.16 Spain Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
8.17 Spain Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.18 Italy Mobile Cardiac Telemetry Systems Market Revenue and Forecasts To 2027 (US$ Mn)
8.18.1 Italy Mobile Cardiac Telemetry Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.19 Italy Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
8.20 Italy Mobile Cardiac Telemetry Systems Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9. Mobile Cardiac Telemetry Systems Market - Industry Landscape
9.1 Overview
9.2 Growth Strategies done by the companies in the Market, (%)
9.3 Developments Done By The Companies
9.3.1 Overview
10. Mobile Cardiac Telemetry Systems Market - Key Company Profiles
10.1 Medtronic
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 BioTelemetry, Inc.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Overview
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Welch Allyn
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Applied Cardiac Systems, Inc.
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Medicomp Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Preventice Solutions, Inc.
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Information
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 The ScottCare Corporation
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Medi-Lynx (Medicalgorithmics S.A.)
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 ZOLL Medical Corporation (Asahi Kasei Corporation)
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Telerhythmics, LLC. (G Medical Innovations Holdings Ltd.)
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Publisher
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic
  • BioTelemetry Inc.
  • Applied Cardiac Systems, Inc
  • Medicomp Inc
  • Preventice Services, LLC
  • The Scottcare Corporation
  • Medi-Lynx (Subisidiary Of Medicalgorithmics, S.A),
  • Zoll Medical Corporation
  • Welch Allyn
  • Telerhythmics, LLC